Literature DB >> 10676432

Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism.

D E Brenneman1, J Hauser, T M Phillips, A Davidson, M Bassan, I Gozes.   

Abstract

Vasoactive intestinal peptide has neurotrophic and neuroprotective properties that influence the survival of activity-dependent neurons in the central nervous system. Investigations of the mechanism of this neurotrophic peptide indicated that these actions are contingent on interactions with astroglia. The complex mixture of neurotrophic mediators released from astroglia include cytokines, a protease inhibitor, and activity-dependent neurotrophic factor, a protein with apparent structural similarities to hsp60. Investigations of ADNF resulted in the discovery of active peptides of extraordinary potency and broad neuroprotective properties. These studies indicate that a nine-amino acid core peptide of ADNF had significantly greater neuroprotective properties in comparison to the parent growth factor and these advantages identify ADNF-9 as an attractive lead compound for drug development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10676432     DOI: 10.1111/j.1749-6632.1999.tb07875.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression.

Authors:  Margarita Ivanova; Stiliana Belcheva; Iren Belcheva; Negrin Negrev; Roman Tashev
Journal:  Psychopharmacology (Berl)       Date:  2011-12-08       Impact factor: 4.530

2.  Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures.

Authors:  Virginia L Smith-Swintosky; Illana Gozes; Douglas E Brenneman; Michael R D'Andrea; Carlos R Plata-Salaman
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  A glia-derived signal regulating neuronal differentiation.

Authors:  O Blondel; C Collin; W J McCarran; S Zhu; R Zamostiano; I Gozes; D E Brenneman; R D McKay
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

Review 4.  Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.

Authors:  Yossan-Var Tan; James A Waschek
Journal:  ASN Neuro       Date:  2011-10-06       Impact factor: 4.146

5.  A neuroanatomical correlate of sensorimotor recovery in response to repeated vaginocervical stimulation in rats.

Authors:  Dina Conde; Barry R Komisaruk
Journal:  Front Physiol       Date:  2012-04-19       Impact factor: 4.566

6.  Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington's Disease Models: Role of PAC1 Receptor.

Authors:  Irene Solés-Tarrés; Núria Cabezas-Llobet; Benjamin Lefranc; Jérôme Leprince; Jordi Alberch; David Vaudry; Xavier Xifró
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.